表紙
市場調查報告書

全球注射型藥物輸送市場規模及分析

Injectable Drug Delivery Market Size, Analysis | Industry Report, 2026

出版商 Coherent Market Insights 商品編碼 883774
出版日期 內容資訊 英文 262 Pages
商品交期: 2-3個工作天內
價格
Back to Top
全球注射型藥物輸送市場規模及分析 Injectable Drug Delivery Market Size, Analysis | Industry Report, 2026
出版日期: 2019年06月28日內容資訊: 英文 262 Pages
簡介

這份報告提供全球注射型藥物輸送市場的相關調查,提供市場趨勢,法規,及趨勢分析,各設備類型·材料·使用性·給藥途徑·終端用戶·各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 研究的目的與前提

  • 研究目的
  • 假設
  • 簡稱

第2章 市場視野

  • 報告的說明
    • 市場定義和範圍
  • 摘要整理
    • 不同設備類型
    • 不同材料
    • 各使用性
    • 各給藥途徑
    • 各終端用戶
    • 各地區

第3章 市場趨勢,法規,及趨勢分析

  • 市場趨勢
    • 成長要素
    • 阻礙因素
    • 市場機會
  • 影響分析
  • 法規方案
  • PEST分析
  • 合作關係與收購方案
  • 最近的產品銷售/核准
  • 技術的演進
  • 市場趨勢

第4章 全球注射型藥物輸送市場:不同設備類型

  • 簡介
  • 預填充式注射器
  • 自動注射器
  • 傳統的注射器
  • 濾芯
  • 安瓿
  • 管瓶
  • 其他

第5章 全球注射型藥物輸送市場:不同材料

  • 簡介
  • 玻璃
  • 塑膠

第6章 全球注射型藥物輸送市場:使用性別

  • 簡介
  • 拋棄式
  • 可重複使用

第7章 全球注射型藥物輸送市場:各給藥途徑

  • 簡介
  • 靜脈內
  • 肌肉內
  • 皮下

第8章 全球注射型藥物輸送市場:各終端用戶

  • 簡介
  • 醫院
  • 診療所
  • 門診病人手術中心
  • 居家照護的設定
  • 其他

第9章 全球注射型藥物輸送市場:各地區

  • 簡介
  • 北美
  • 南美
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第10章 競爭環境

  • 熱圖分析
  • 企業簡介
    • Becton, Dickinson and Company
    • Pfizer Inc.
    • Novo Nordisk A/S
    • Gerresheimer AG
    • Carl-Zeiss-Stiftung
    • Terumo Corporation
    • Vetter Pharma-Fertigung GmbH & Co. KG
    • SHL Group
    • Owen Mumford Limited
    • Injex Pharma GmbH
  • 分析師的意見

第11章 章節

  • 參考文獻
  • 調查方法
  • 企業資料及銷售相關資料

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Injectables offer maximum bioavailability of drugs towards the intended site of action and avoid the first pass metabolism. The injectable route is mostly preferred for the drugs which can't be taken orally or have some stability problems. Unconscious patients or patients having low compliance towards oral tablets or capsules can be preferred for the injectable drug delivery therapy.

Market Dynamics:

Increasing prevalence of chronic diseases such as diabetes, cardiac diseases, and anaphylaxis has supported growth of global injectable drug delivery market. According to the Allergy, Asthma & Clinical Immunology, in 2015, around 15 million people suffered from food allergies in the U.K. Similarly, according to the European Academy of Allergy and Clinical Immunology (EAACI), in 2015, around 17 million people suffered from food allergies in the U.K., of which around 3.5 million were children. Increasing awareness regarding safety and concern of needlestick injuries is a major factor driving growth of the injectable drug delivery market. For instance, the WHO recommended the use of safety syringes with sharp injury protection (SIP), in order to prevent needlestick injuries. Similarly, in May 2017, Innovative Neurons LLC announced to commercialize its patented auto retractable multi-needle syringe known as FAST (fast, accessible, safe, and technology) to decrease needlestick injuries. Various market players are focusing on the development and advancement in this space. For instance, ACT-O-VIAL System offered by Pfizer Inc. is a dual-component vial system that allows reconstitution of sterile, injectable medications by pressing on the plastic cap. The facility launch by market players to cater requirements of patients is expected to drive the market growth. For instance, in July 2018, Pfizer, Inc. announced to build sterile injectable pharmaceutical production facilities in the Michigan, U.S.

However, product recalls by the manufacturers is the major factors restraining the market over the forecast period. For instance, in April 2018, Becton Dickson and Company announced a recall of PosiFlush Heaparin Lock Flush Syringe, and Prefilled normal saline syringe, owing to the contamination with Serratia marcescens bacterium.

Key features of the study:

  • This report provides in-depth analysis of the injectables drug delivery market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2018 - 2026), considering 2017 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the global injectable drug delivery market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Becton, Dickinson and Company, Pfizer Inc., Novo Nordisk A/S, Gerresheimer AG, Carl-Zeiss-Stiftung, Terumo Corporation, Vetter Pharma-Fertigung GmbH & Co. KG, SHL Group, Owen Mumford Limited, Injex Pharma GmbH.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics.
  • The global injectables drug delivery market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global injectable drug delivery market

Detailed Segmentation:

  • Global Injectable Drug Delivery Market, By Device Type:
    • Prefilled Syringes
    • Auto Injectors
    • Pens
    • Conventional Syringes
    • Cartridges
    • Ampoules
    • Vials
    • Others
  • Global Injectable Drug Delivery Market, By Material Type:
    • Glass
    • Plastic
  • Global Injectable Drug Delivery Market, By Usability:
    • Disposable
    • Reusable
  • Global Injectable Drug Delivery Market, By Route of Administration:
    • Intravenous
    • Intramuscular
    • Subcutaneous
  • Global Injectable Drug Delivery Market, By End User:
    • Hospitals
    • Clinics
    • Ambulatory Surgical Centers
    • Home Care Settings
    • Others
  • Global Injectable Drug Delivery Market, By Region:
    • North America
      • By Device Type:
      • Prefilled Syringes
      • Auto Injectors
      • Pens
      • Conventional Syringes
      • Cartridges
      • Ampoules
      • Vials
      • Others
      • By Material Type:
      • Glass
      • Plastic
      • By Usability:
      • Disposable
      • Reusable
      • By Route of Administration:
      • Intravenous
      • Intramuscular
      • Subcutaneous
      • By End User:
      • Hospitals
      • Clinics
      • Ambulatory Surgical Centers
      • Home Care Settings
      • Others
      • By Country:
      • U.S.
      • Canada
    • Latin America
      • By Device Type:
      • Prefilled Syringes
      • Auto Injectors
      • Pens
      • Conventional Syringes
      • Cartridges
      • Ampoules
      • Vials
      • Others
      • By Material Type:
      • Glass
      • Plastic
      • By Usability:
      • Disposable
      • Reusable
      • By Route of Administration:
      • Intravenous
      • Intramuscular
      • Subcutaneous
      • By End User:
      • Hospitals
      • Clinics
      • Ambulatory Surgical Centers
      • Home Care Settings
      • Others
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Device Type:
      • Prefilled Syringes
      • Auto Injectors
      • Pens
      • Conventional Syringes
      • Cartridges
      • Ampoules
      • Vials
      • Others
      • By Material Type:
      • Glass
      • Plastic
      • By Usability:
      • Disposable
      • Reusable
      • By Route of Administration:
      • Intravenous
      • Intramuscular
      • Subcutaneous
      • By End User:
      • Hospitals
      • Clinics
      • Ambulatory Surgical Centers
      • Home Care Settings
      • Others
      • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Device Type:
      • Prefilled Syringes
      • Auto Injectors
      • Pens
      • Conventional Syringes
      • Cartridges
      • Ampoules
      • Vials
      • Others
      • By Material Type:
      • Glass
      • Plastic
      • By Usability:
      • Disposable
      • Reusable
      • By Route of Administration:
      • Intravenous
      • Intramuscular
      • Subcutaneous
      • By End User:
      • Hospitals
      • Clinics
      • Ambulatory Surgical Centers
      • Home Care Settings
      • Others
      • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Device Type:
      • Prefilled Syringes
      • Auto Injectors
      • Pens
      • Conventional Syringes
      • Cartridges
      • Ampoules
      • Vials
      • Others
      • By Material Type:
      • Glass
      • Plastic
      • By Usability:
      • Disposable
      • Reusable
      • By Route of Administration:
      • Intravenous
      • Intramuscular
      • Subcutaneous
      • By End User:
      • Hospitals
      • Clinics
      • Ambulatory Surgical Centers
      • Home Care Settings
      • Others
      • By Country:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Device Type:
      • Prefilled Syringes
      • Auto Injectors
      • Pens
      • Conventional Syringes
      • Cartridges
      • Ampoules
      • Vials
      • Others
      • By Material Type:
      • Glass
      • Plastic
      • By Usability:
      • Disposable
      • Reusable
      • By Route of Administration:
      • Intravenous
      • Intramuscular
      • Subcutaneous
      • By End User:
      • Hospitals
      • Clinics
      • Ambulatory Surgical Centers
      • Home Care Settings
      • Others
      • By Country/Region:
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Becton, Dickinson and Company*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Pfizer Inc.
    • Novo Nordisk A/S
    • Gerresheimer AG
    • Carl-Zeiss-Stiftung
    • Terumo Corporation
    • Vetter Pharma-Fertigung GmbH & Co. KG
    • SHL Group
    • Owen Mumford Limited
    • Injex Pharma GmbH

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Device Type
    • Market Snippet, By Material Type
    • Market Snippet, By Usability
    • Market Snippet, By Route of Administration
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Regulatory Scenario
  • PEST Analysis
  • Partnership and Acquisition Scenario
  • Recent Product Launches/Approvals
  • Technological Evolution
  • Market Trends

4. Global Injectable Drug Delivery Market, By Device Type, 2018 - 2026, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Prefilled Syringes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Auto Injectors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Pens
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Conventional Syringes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Cartridges
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Ampoules
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Vials
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)

5. Global Injectable Drug Delivery Market, By Material Type, 2018 - 2026, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Glass
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Plastic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)

6. Global Injectable Drug Delivery Market, By Usability, 2018 - 2026, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Disposable
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Reusable
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)

7. Global Injectable Drug Delivery Market, By Route of Administration, 2018 - 2026, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Intravenous
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Intramuscular
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Subcutaneous
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)

8. Global Injectable Drug Delivery Market, By End User, 2018 - 2026, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Home Care Settings
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)

9. Global Injectable Drug Delivery Market, By Region, 2018 - 2026, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2026
  • North America
    • Market Size and Forecast, By Device Type, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Material Type, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Usability, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Route of Administration, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Device Type, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Material Type, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Usability, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Route of Administration, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Device Type, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Material Type, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Usability, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Route of Administration, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Device Type, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Material Type, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Usability, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Route of Administration, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of APAC
  • Middle East
    • Market Size and Forecast, By Device Type, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Material Type, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Usability, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Route of Administration, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Device Type, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Material Type, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Usability, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Route of Administration, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Country/Region, 2016 - 2026, (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

10. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • Becton, Dickinson and Company
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Pfizer Inc.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Novo Nordisk A/S
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Gerresheimer AG
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Carl-Zeiss-Stiftung
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Terumo Corporation
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Vetter Pharma-Fertigung GmbH & Co. KG
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • SHL Group
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Owen Mumford Limited
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Injex Pharma GmbH
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Analyst Views

11. Section

  • References
  • Research Methodology
  • About us and Sales Contact
Back to Top